Takahisa Kawaguchi

Takahisa Kawaguchi

Auto-generated profile, based on publicly available information

Takahisa Kawaguchi

Center for Genomic Medicine, Kyoto University Graduate School of Medicine , Kyoto

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TKTakahisa Kawaguchi
Takahisa Kawaguchi
TSToshihide Shima
Toshihide Shima
MMMasayuki Mizuno
Masayuki Mizuno
YMYasuhide Mitsumoto
Yasuhide Mitsumoto
Atsushi UmemuraAtsushi Umemura
Atsushi Umemura
TOTakeshi Okanoue
Takeshi Okanoue
The genetic factors affecting the natural history of nonalcoholic fatty liver disease (NAFLD), including the development of nonalcoholic steatohepatitis (NASH) and NASH-derived hepatocellular carcinoma (NASH-HCC), are still unknown. In the current study, we sought to identify genetic factors related to the development of NAFLD, NASH, and NASH-HCC, and to establish risk-estimation models for them. For these purposes, 936 histologically proven NAFLD patients were recruited, and genome-wide association (GWA) studies were conducted for 902, including 476 NASH and 58 NASH-HCC patients, against 7,672 general-population controls. Risk estimations for NAFLD and NASH were then performed using the SNPs identified as having significant associations in the GWA studies. We found that rs2896019 in PNPLA3 [p = 2.3x10-31, OR (95%CI) = 1.85 (1.67–2.05)], rs1260326 in GCKR [p = 9.6x10-10, OR (95%CI) = 1.38(1.25–1.53)], and rs4808199 in GATAD2A [p = 2.3x10-8, OR (95%CI) = 1.37 (1.23–1.53)] were significantly associated with NAFLD. Notably, the number of risk alleles in PNPLA3 and GATAD2A was much higher in Matteoni type 4 (NASH) patients than in type 1, type 2, and type 3 NAFLD patients. In addition, we newly identified rs17007417 in DYSF [p = 5.2x10-7, OR (95%CI) = 2.74 (1.84–4.06)] as a SNP associated with NASH-HCC. Rs641738 in TMC4, which showed association with NAFLD in patients of European descent, was not replicated in our study (p = 0.73), although the complicated LD pattern in the region suggests the necessity for further investigation. The genetic variants of PNPLA3, GCKR, and GATAD2A were then used to estimate the risk for NAFLD. The obtained Polygenic Risk Scores showed that the risk for NAFLD increased with the accumulation of risk alleles [AUC (95%CI) = 0.65 (0.63–0.67)]. Conclusions: We demonstrated that NASH is genetically and clinically different from the other NAFLD subgroups. We also established risk-estimation models for NAFLD and NASH using multiple genetic markers. These models can be used to improve the accuracy of NAFLD diagnosis and to guide treatment decisions for patients.

1 August 2019 in Journal of Urology
Verified
Journal Article
Closed access
AFArinobu Fukunaga
Arinobu Fukunaga
TKTakahisa Kawaguchi
Takahisa Kawaguchi
SFSatoshi Funada
Satoshi Funada
TYTakayuki Yoshino
Takayuki Yoshino
YTYasuharu Tabara
Yasuharu Tabara
OGon behalf of the Nagahama Study Group
on behalf of the Nagahama Study Group
Purpose:Multiple factors are associated with lower urinary tract symptoms (LUTS), and sleep disturbance is well known to be associated with nocturia. The association between sleep disturbance and LUTS has not been sufficiently elucidated. Here we evaluated the impact of sleep disturbance on LUTS, especially voiding symptoms, in the Nagahama Study.Participantsand Methods: The Nagahama Study is a prospective cohort study of healthy individuals. Among them, participants ≥50 years old who completed both the International Prostate Symptom Score [IPSS] questionnaire and a sleep problem questionnaire were included in this analysis and followed-up for 5 years. Sleep disturbance was stratified into poor sleep quality, sleep restriction and sleep medication use. We analyzed the association between sleep disturbance and the worsening of LUTS adjusted by various clinical factors in a multivariate logistic regression analysis.Results:Among the 5,297 participants, the prevalence of LUTS at baseline was 23% and ...

26 January 2024 in Science Advances
Verified
Journal Article
Open access
YKYuriko N. Koyanagi
Yuriko N. Koyanagi
MNMasahiro Nakatochi
Masahiro Nakatochi
SNShinichi Namba
Shinichi Namba
IOIsao Oze
Isao Oze
HCHadrien Charvat
Hadrien Charvat
Keitaro MatsuoKeitaro Matsuo
Keitaro Matsuo
An East Asian–specific variant on aldehyde dehydrogenase 2 ( ALDH2 rs671, G>A) is the major genetic determinant of alcohol consumption. We performed an rs671 genotype-stratified genome-wide association study meta-analysis of alcohol consumption in 175,672 Japanese individuals to explore gene-gene interactions with rs671 behind drinking behavior. The analysis identified three genome-wide significant loci ( GCKR , KLB , and ADH1B ) in wild-type homozygotes and six ( GCKR , ADH1B , ALDH1B1 , ALDH1A1 , ALDH2 , and GOT2 ) in heterozygotes, with five showing genome-wide significant interaction with rs671. Genetic correlation analyses revealed ancestry-specific genetic architecture in heterozygotes. Of the discovered loci, four ( GCKR , ADH1B , ALDH1A1 , and ALDH2 ) were suggested to interact with rs671 in the risk of esophageal cancer, a representative alcohol-related disease. Our results identify the genotype-specific genetic architecture of alcohol consumption and reveal its potential impact on alcohol-related disease risk.

1 May 2017 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
YTYasuharu Tabara
Yasuharu Tabara
HAHidenori Arai
Hidenori Arai
YHYuhko Hirao
Yuhko Hirao
YTYoshimitsu Takahashi
Yoshimitsu Takahashi
KSKazuya Setoh
Kazuya Setoh
FMFumihiko Matsuda
Fumihiko Matsuda

16 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MPMarina Penova
Marina Penova
SKShuji Kawaguchi
Shuji Kawaguchi
JYJun-ichirou Yasunaga
Jun-ichirou Yasunaga
TKTakahisa Kawaguchi
Takahisa Kawaguchi
TSTomoo Sato
Tomoo Sato
FMFumihiko Matsuda
Fumihiko Matsuda
Significance: Human T cell leukemia virus type 1 (HTLV-1) proviral load is associated with the risk of developing HTLV-1–associated myelopathy/tropical spastic paraparesis (HAM/TSP) and several small-scale candidate gene approaches have also identified associations of particular HLA alleles with HAM/TSP risk. However, no large-scale genome-wide association (GWA) studies have been performed to date. By a large-scale GWA study and comprehensive genotyping of classical HLA genes, we found that HLA-DRB1 alleles carrying leucine at the antigen presentation groove domain (DRB1-GB-7-Leu) increased the susceptibility to HAM/TSP. Individuals who were homozygous for DRB1-GB-7-Leu had a ninefold increased odds of developing HAM/TSP. This effect of DRB1-GB-7-Leu was independent of proviral load. These findings identify DRB1-GB-7-Leu as a genetic risk marker of HAM/TSP development.

23 November 2023 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
MKMisaki Kanezawa
Misaki Kanezawa
HSHiroto Shimokawahara
Hiroto Shimokawahara
MTMasahiro Tsuji
Masahiro Tsuji
KSKazuki Suruga
Kazuki Suruga
AMAyane Miyagi
Ayane Miyagi
HMHiromi Matsubara
Hiromi Matsubara
Peripheral pulmonary arterial stenosis (PPAS) is commonly observed in paediatric patients with associated congenital heart disease or systemic congenital syndromes, such as tetralogy of Fallot and Williams syndrome [1]. Meanwhile, isolated PPAS without other structural heart disease or systemic congenital syndromes is primarily reported in adulthood [2]. Recent genetic analyses have revealed that four cases of isolated PPAS in adulthood were homozygous for the ring finger protein 213 (RNF213) p.Arg4810Lys variant (also referred to as G to A alteration of rs112735431 and NM_001256071.3:c.14429G>A) [3]. RNF213 p.Arg4810Lys is a genetic determinant in moyamoya disease (MMD) in East Asians [4]. This genetic variant is unique to East Asians and is reported to have a frequency of approximately 0.8% in the general Japanese population [5, 6]. However, its prevalence in adult patients with isolated PPAS remains unknown.